Cue Health Inc. Research and Development Expense
Cue Health Inc. reported Research and Development Expense of $150.62 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-03-13
- Cue Health Inc. research and development expense for the quarter ending 2023-12-31 was $32.25M, a 42.57% decline year-over-year.
- Cue Health Inc. research and development expense for the quarter ending 2023-09-30 was $37.10M, a 12.73% decline year-over-year.
- Cue Health Inc. research and development expense for the quarter ending 2023-06-30 was $36.54M, a 16.96% decline year-over-year.
- Cue Health Inc. research and development expense for the quarter ending 2023-03-31 was $44.73M, a 55.39% increase year-over-year.
- Cue Health Inc. research and development expense for fiscal 2023 was $150.62M, a 12.15% decline from fiscal 2022.
- Cue Health Inc. research and development expense for fiscal 2022 was $171.45M, a 300.32% increase from fiscal 2021.
- Cue Health Inc. research and development expense for fiscal 2021 was $42.83M, a 50.39% increase from fiscal 2020.
- Cue Health Inc. research and development expense for fiscal 2020 was $28.48M, a 33.04% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $32.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $69.35M derived: sum of 2 quarters · filed 2024-03-13 | $105.89M derived: sum of 3 quarters · filed 2024-03-13 | $150.62M 10-K · filed 2024-03-13 |
| 2023-09-30 | $37.10M 10-Q · filed 2023-11-08 | $73.64M derived: sum of 2 quarters · filed 2023-11-08 | $118.37M 10-Q · filed 2023-11-08 | $174.52M derived: sum of 4 quarters · filed 2024-03-13 |
| 2023-06-30 | $36.54M 10-Q · filed 2023-08-09 | $81.27M 10-Q · filed 2023-08-09 | $137.42M derived: sum of 3 quarters · filed 2024-03-13 | $179.93M derived: sum of 4 quarters · filed 2024-03-13 |
| 2023-03-31 | $44.73M 10-Q · filed 2023-05-10 | $100.88M derived: sum of 2 quarters · filed 2024-03-13 | $143.40M derived: sum of 3 quarters · filed 2024-03-13 | $187.40M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-12-31 | $56.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $98.67M derived: sum of 2 quarters · filed 2024-03-13 | $142.66M derived: sum of 3 quarters · filed 2024-03-13 | $171.45M 10-K · filed 2024-03-13 |
| 2022-09-30 | $42.52M 10-Q · filed 2023-11-08 | $86.52M derived: sum of 2 quarters · filed 2023-11-08 | $115.30M 10-Q · filed 2023-11-08 | $136.98M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $44.00M 10-Q · filed 2023-08-09 | $72.79M 10-Q · filed 2023-08-09 | $94.47M derived: sum of 3 quarters · filed 2024-03-13 | $103.55M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $28.79M 10-Q · filed 2023-05-10 | $50.47M derived: sum of 2 quarters · filed 2024-03-13 | $59.55M derived: sum of 3 quarters · filed 2024-03-13 | $64.21M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $21.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $30.76M derived: sum of 2 quarters · filed 2024-03-13 | $35.42M derived: sum of 3 quarters · filed 2024-03-13 | $42.83M 10-K · filed 2024-03-13 |
| 2021-09-30 | $9.08M 10-Q · filed 2022-11-09 | $13.74M derived: sum of 2 quarters · filed 2022-11-09 | $21.15M 10-Q · filed 2022-11-09 | $23.07M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $4.66M 10-Q · filed 2022-08-10 | $12.07M 10-Q · filed 2022-08-10 | $13.99M derived: sum of 3 quarters · filed 2023-03-16 | $20.87M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $7.41M 10-Q · filed 2022-05-11 | $9.33M derived: sum of 2 quarters · filed 2023-03-16 | $16.21M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2020-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $8.80M derived: sum of 2 quarters · filed 2023-03-16 | $28.48M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $6.88M 10-Q · filed 2021-11-10 | $26.56M 10-Q · filed 2021-11-10 | ||
| 2019-12-31 | $21.41M 10-K · filed 2022-03-29 |